Key result
Multiple sclerosis was associated with significantly higher cross-reactivity to HIV-1 and HIV-2 reverse transcriptase fragments and HTLV-1 p24 compared to control groups.
Why the study?
Is there cross-reactivity with retroviral proteins in sera from patients with multiple sclerosis compared to controls?
Case-Control
Is there cross-reactivity with retroviral proteins in sera from patients with multiple sclerosis compared to controls?
Sera from MS patients show frequent cross-reactivity with retroviral proteins, suggesting a potential retroviral etiology for multiple sclerosis.
Hypothesis-generating for retroviral role in MS; does not yet inform clinical practice.
HTLV-1, HIV-1 and HIV-2 western blot analysis of sera from patients with multiple sclerosis (MS), from patients with other neurological diseases and from blood donors, revealed a rather frequent cross-reactivity with retroviral proteins in the MS group, though no patient was positive with the corresponding specific ELISA serology. Statistical analysis revealed a significant difference between the MS group and the two control groups for HIV-1 and HIV-2 reverse transcriptase fragments and for HTLV-1 p24. The general significance of these observations is discussed in the light of a retroviral hypothesis for the aetiology of MS. It is suggested that, if a retrovirus is present in MS patients, it does not necessarily belong to the HTLV sub-family and could as well be a lentivirus, like Visna virus, the causative agent of a demyelinating disease in sheep which is one--natural--model for MS.
No takes yet. Share an insight, caveat, or question.
Perron et al. (1991) conducted a case-control in Multiple sclerosis. Multiple sclerosis vs. Patients with other neurological diseases and blood donors was evaluated on Cross-reactivity with retroviral proteins (HIV-1 and HIV-2 reverse transcriptase fragments and HTLV-1 p24). Multiple sclerosis was associated with significantly higher cross-reactivity to HIV-1 and HIV-2 reverse transcriptase fragments and HTLV-1 p24 compared to control groups.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: